By Erin Migdol in The Mighty.
One of the biggest challenges of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is no definitive test exists yet to prove you have the condition, making it difficult for patients to get diagnosed — and, in many cases, to prove there is even anything “wrong” with you at all — or find the right treatment. But a new study was able to predict ME/CFS with a high degree of accuracy, adding to the growing body of research that supports the possibility of a blood test for ME/CFS.
What the Research Says
The study, published in the journal “Scientific Reports” earlier this month, looked at data from 50 patients with ME/CFS and 50 healthy controls. Researchers analyzed 562 metabolites, or substances made or used when the body breaks down food, chemicals or its own tissue in blood plasma, and looked at how these metabolites were different in people with and without ME/CFS.
Using a few of the biomarkers that were found to distinguish ME/CFS subjects from the control group most strongly, researchers were able to predict which patients had ME/CFS with an accuracy rate of 84 percent.
To read the rest of this story, click on the link below: